XML 81 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based and Long-Term Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity during the three months ended March 31, 2020:

 

 

 

Options

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Contractual

Term

Remaining

(in years)

 

 

Aggregate

Intrinsic Value

(in thousands)

 

Outstanding as of December 31, 2019

 

 

9,564,202

 

 

$

19.85

 

 

 

5.43

 

 

$

156,270

 

Exercised

 

 

(498,753

)

 

 

14.66

 

 

 

 

 

 

 

Forfeited

 

 

(54,098

)

 

 

15.96

 

 

 

 

 

 

 

Expired

 

 

(20,442

)

 

 

23.32

 

 

 

 

 

 

 

Outstanding as of March 31, 2020

 

 

8,990,909

 

 

 

20.16

 

 

 

5.15

 

 

 

85,351

 

Exercisable as of March 31, 2020

 

 

8,616,016

 

 

$

20.22

 

 

 

5.05

 

 

$

81,226

 

 

Stock options typically have a contractual term of ten years from grant date.

Summary of Restricted Stock Unit Activity

The following table summarizes restricted stock unit activity for the three months ended March 31, 2020:

 

 

 

Number of Units

 

 

Weighted Average

Grant-Date Fair

Value Per Unit

 

Outstanding as of December 31, 2019

 

 

6,541,224

 

 

$

18.77

 

Granted

 

 

2,298,993

 

 

 

35.44

 

Vested

 

 

(1,963,611

)

 

 

17.91

 

Forfeited

 

 

(265,953

)

 

 

23.85

 

Outstanding as of March 31, 2020

 

 

6,610,653

 

 

$

24.62

 

The grant-date fair value of restricted stock units is the closing price of the Company’s ordinary shares on the date of grant.
Summary of Performance Stock Unit Awards (PSUs) Activity

The following table summarizes performance stock unit awards (“PSUs”) activity for the three months ended March 31, 2020:

 

 

 

Number

of Units

 

 

Weighted

Average

Grant-Date

Fair Value

Per Unit

 

 

Average

Illiquidity

Discount

 

 

 

Recorded

Weighted

Average

Fair Value

Per Unit

 

Outstanding as of December 31, 2019

 

 

3,558,900

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

587,802

 

 

$

42.38

 

 

 

8.1

%

 

 

$

38.94

 

Forfeited

 

 

(201,645

)

 

 

25.73

 

 

 

4.3

%

 

 

 

24.62

 

Vested

 

 

(1,380,312

)

 

 

20.85

 

 

 

0.0

%

 

 

 

20.85

 

Performance Based Adjustment (1)

 

 

89,941

 

 

 

20.24

 

 

 

0.0

%

 

 

 

20.24

 

Outstanding as of March 31, 2020

 

 

2,654,686

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)

Represents adjustment based on the net sales performance criteria meeting 119.2% of target as of December 31, 2019 for the 2019 PSUs (as defined below).

 

Summary of Significant Valuation Assumptions Related to 2020 PSUs

All PSUs outstanding at March 31, 2020 may vest in a range of between 0% and 200%, based on the performance metrics described above.  The Company accounts for the 2019 PSUs and 2020 PSUs as equity-settled awards in accordance with ASC 718.  Because the value of the 2019 Relative TSR PSUs and 2020 Relative TSR PSUs are dependent upon the attainment of a level of TSR, it requires the impact of the market condition to be considered when estimating the fair value of the 2019 Relative TSR PSUs and 2020 Relative TSR PSUs.  As a result, the Monte Carlo model is applied and the most significant valuation assumptions used related to the 2020 PSUs during the three months ended March 31, 2020, include:

Valuation date stock price

 

$

36.10

 

Expected volatility

 

 

47.3

%

Risk free rate

 

 

1.5

%

 

Summary of Share-Based Compensation Expense

The following table summarizes share-based compensation expense included in the Company’s condensed consolidated statements of operations for the three months ended March 31, 2020 and 2019 (in thousands):

 

 

 

For the Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

Share-based compensation expense

 

 

 

 

 

 

 

 

Cost of goods sold

 

$

2,689

 

 

$

1,039

 

Research and development

 

 

6,376

 

 

 

2,636

 

Selling, general and administrative

 

 

47,356

 

 

 

23,873

 

Total share-based compensation expense

 

$

56,421

 

 

$

27,548